Medically reviewed by Lindsay Cook, PharmD Narcolepsy is a chronic brain disorder that disrupts sleep-wake cycles. People ...

For people living with narcolepsy, no amount of sleep alleviates the feeling of being tired. While most people are either awake or asleep, narcolepsy feels as if you're never really in either state.

Mazindol ER is under clinical development by NLS Pharmaceutics and currently in Phase II for Narcolepsy. According to GlobalData, Phase II drugs for Narcolepsy have a 59% phase transition success rate ...

For people living with narcolepsy, no amount of sleep alleviates the feeling of being tired. While most people are either awake or asleep, narcolepsy feels as if you're never really in either state.

I feel myself weightless, but like I literally cannot move. I thought narcolepsy was what we saw on TV. I had no basis for understanding it, and I never done my own research to actually figure out ...

People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive ...

In a report released yesterday, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Centessa Pharmaceuticals (CNTA – Research ...

Axsome Therapeutics shows strong revenue growth with promising pipeline drugs for migraine, fibromyalgia, and narcolepsy.

Centessa Pharmaceuticals, founded from the merger of 10 biotech companies, is based on an asset-centric model, primarily ...

Ginger Zee provided her fans with a brief health update after undergoing what she described as an “important test.” The Good ...

Axsome Therapeutics has announced that its investigational narcolepsy therapy has met the primary endpoint in a Phase III trial. AXS-12 (reboxetine), the norepinephrine reuptake inhibitor and ...